Effect of a dopaminergic drug on LH, FSH and prolactin levels in PCO syndrome.
D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology*; D007986:Luteinizing Hormone / Q000097:blood*; D009627:Nomifensine / Q000494:pharmacology*; D010906:Pituitary Hormone-Releasing Hormones; D011085:Polycystic Ovary Syndrome / Q000097:blood*; D011388:Prolactin / Q000097:blood*
D007546:Isoquinolines; D010906:Pituitary Hormone-Releasing Hormones; D009627:Nomifensine; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone